Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Compare Glide Path and Equal Weight strategies to understand which fits your retirement goals. Learn key differences, risks, and practical steps to apply in your portfolio.
26,443 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Bitcoin braces for the July CPI report as traders weigh potential Fed tightening. A hotter print could push BTC lower...
The demographic shift toward an older homebuyer is altering demand in housing markets. This article explains how an a...
A potential rollback of steel and aluminum tariffs could reshape costs for major beverage makers and packaging firms....
Investor chatter centers on which these companies benefits most as U.S.-China tariff talks re-emerge. A closer look a...
Marvell Technology has staged a decisive run in 2026, outpacing Broadcom in the AI accelerator stock race. As data-ce...
Walmart and Google roll out Gemini-powered checkout, triggering a shift in which stocks investors should watch. This ...
Aurora Mobile's Q1 2026 earnings reveal a mix of solid growth and evolving margins. This piece breaks down what the t...
Nvidia stands at the center of the AI boom. This piece lays out why could nvidia reach trillion is a real, trackable ...
Investors are eyeing space names as the industry expands. This guide dives into Redwire, asks if it can be a redwire ...
A Thursday rally put Oklo in the spotlight after a strategic supply agreement. This piece breaks down what happened, ...
A SpaceX AI push could rewrite how we think about tech bets. If spacex just spent billion, investors should watch how...